Two weeks after the European Medicines Agency first assured EU member states it had found no link between the Oxford/AstraZeneca vaccine and earlier reports of rare blood clots, a growing number of countries have announced new restrictions on the use of the jab.
兩週前，歐洲藥品管理局(European Medicines Agency)首次向歐盟成員國保證，它沒有發現牛津/阿斯特捷利康(Oxford/AstraZeneca)疫苗與早些時候報告的罕見血栓病例存在聯繫，而現在已有越來越多的國家宣佈限制接種該疫苗。
您已閱讀4%（386字），剩餘96%（9573字）包含更多重要資訊，訂閱以繼續探索完整內容，並享受更多專屬服務。
